Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy-Reference-Cited by-同舟云学术

Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy

Published:2012-04 Issue:4 Volume:37 Page:325-331
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Giovacchini Giampiero,Picchio Maria,Parra Rita G.,Briganti Alberto,Gianolli Luigi,Montorsi Francesco,Messa Cristina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. . Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.;Amling;J Urol,2000

2. . Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.;Partin;Urology,1994

3. . Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen.;Patel;J Urol,1997

4. . Natural history of progression after PSA elevation following radical prostatectomy.;Pound;JAMA,1999

5. . Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.;Patel;J Clin Oncol,2005

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relación de las cinéticas del PSA en la detección de la recurrencia del cáncer de próstata post prostatectomía radical con la 18f-colina tomografía por emisión de positrones/tomografía computada [PET/TC colina (PETC)];Revista Argentina de Radiología / Argentinian Journal of Radiology;2020-09

2. “Real-world” evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy;Urologic Oncology: Seminars and Original Investigations;2020-01

3. TEP/TDM 18F-choline dans les récidives biologiques des cancers de la prostate traites par radiothérapie externe ou curiethérapie : impact du PSA et de sa cinétique;Médecine Nucléaire;2020-01

4. Cancers de la prostate;Médecine Nucléaire;2019-01

5. A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer;Future Oncology;2018-05